Congo vs Mauritius: Estimated antiretroviral therapy coverage among people living with HIV
Congo
35.0%
in 2025
Mauritius
36.0%
in 2025
Congo rank
135th
Mauritius rank
134th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Congo
- Mauritius
How they compare
Mauritius currently reports 36.0% against 35.0% in Congo, a difference of 1.0%.
The two have swapped places 4 times across 26 shared years of data; in 2000 it was Mauritius ahead.
Congo ranks 135th and Mauritius ranks 134th of 143 countries.
Across the 3 decades both report, Congo averaged higher in 1 and Mauritius in 2.
Head to head by decade
| Decade | Congo | Mauritius | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.7% | 2.9% | 0.8% | Congo |
| 2010s | 19.8% | 20.5% | 0.7% | Mauritius |
| 2020s | 29.5% | 30.7% | 1.2% | Mauritius |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Congo or Mauritius?
- Mauritius, at 36.0% against 35.0% in Congo as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Congo and Mauritius?
- 1.0%, with Mauritius ahead.
- How many years of comparable data are there for Congo and Mauritius?
- 26 years are reported by both, from 2000 to 2025.
- How do Congo and Mauritius rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Congo ranks 135th and Mauritius ranks 134th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.